Page 228 - Vitamin D and Cancer

9 Molecular Biology of Vitamin D Metabolism and Skin Cancer 215

52. Freedman LP (1999) Multimeric coactivator complexes for steroid/nuclear receptors. Trends
Endocrinol Metab 10(10):403–407
53. Fritsche J, Mondal K, Ehrnsperger A et al (2003) Regulation of 25-hydroxyvitamin D3–1
alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic
cells. Blood 102(9):3314–3316
54. Fu GK, Lin D, Zhang MY et al (1997) Cloning of human 25-hydroxyvitamin D-1 alpha-
hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol
11(13):1961–1970
55. Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon
cancer? Int J Epidemiol 9(3):227–231
56. Garland FC, Garland CF, Gorham ED et al (1990) Geographic variation in breast cancer
mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med
19(6):614–622
57. Geller AC, Swetter SM, Brooks K et al (2007) Screening, early detection, and trends for
melanoma: current status (2000–2006) and future directions. J Am Acad Dermatol
57(4):555–572, quiz 73–6
58. Goltzman D, White J, Kremer R (2001) Studies of the effects of 1, 25-dihydroxyvitamin D
on skeletal and calcium homeostasis and on inhibition of tumor cell growth. J Steroid
Biochem Mol Biol 76(1–5):43–47
59. Green A, MacLennan R, Youl P et al (1993) Site distribution of cutaneous melanoma in
Queensland. Int J Cancer 53(2):232–236
60. Grover SR, Morley R (2001) Vitamin D deficiency in veiled or dark-skinned pregnant
women. Med J Aust 175(5):251–252
61. Gupta R, Dixon KM, Deo SS et al (2007) Photoprotection by 1, 25 dihydroxyvitamin D3 is
associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol
127(3):707–715
62. Hansen CM, Hamberg KJ, Binderup E et al (2000) Seocalcitol (EB 1089): a vitamin D analogue
of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr
Pharm Des 6(7):803–828
63. Haussler MR, Whitfield GK, Haussler CA et al (1998) The nuclear vitamin D receptor:
biological and molecular regulatory properties revealed. J Bone Miner Res 13(3):325–349
64. Hawker NP, Pennypacker SD, Chang SM et al (2007) Regulation of human epidermal kera-
tinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and
SRC3. J Invest Dermatol 127(4):874–880
65. Hewison M, Freeman L, Hughes SV et al (2003) Differential regulation of vitamin D receptor
and its ligand in human monocyte-derived dendritic cells. J Immunol 170(11):5382–5390
66. Holick MF (1994) McCollum Award Lecture, 1994: vitamin D–new horizons for the 21st
century. Am J Clin Nutr 60(4):619–630
67. Holick MF (1996) Vitamin D and bone health. J Nutr 126(4 Suppl):1159S–1164S
68. Holick MF (2001) Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle
weakness. Lancet 357(9249):4–6
69. Holick MF (2003) Evolution and function of vitamin D. Recent Results Cancer Res 164:3–28
70. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D suffi-
ciency: implications for establishing a new effective dietary intake recommendation for
vitamin D. J Nutr 135(2):317–322
71. Holman CD, Armstrong BK (1984) Cutaneous malignant melanoma and indicators of total
accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer
Inst 73(1):75–82
72. Horiuchi N, Clemens TL, Schiller AL et al (1985) Detection and developmental changes of
the 1, 25-(OH)2–D3 receptor concentration in mouse skin and intestine. J Invest Dermatol
84(6):461–464
73. Hosomi J, Hosoi J, Abe E et al (1983) Regulation of terminal differentiation of cultured mouse
epidermal cells by 1 alpha, 25-dihydroxyvitamin D3. Endocrinology 113(6):1950–1957